FIGURE 1.
Integrative analysis to identify dysregulated pathways in FTLD-Tau. (A) MAPT gene annotated with the location of the mutations used in this study. Lower left panel displays the six major isoforms expressed in the central nervous system. (B) Comparison of human iPSC-neurons carrying the MAPT mutation specific and isogenic controls served as a discovery cohort to identify genes dysregulated across the three mutations. (C) Overlap analysis between all mutants compared with control. After multiple test corrections (BY-FDR ≤ 0.05), we identified 11 commonly differentially expressed genes. (D) Functional annotation was performed using the commonly differentially expressed genes.